RecruitingPhase 3NCT03770923

Effect of Some Drugs on Rheumatoid Arithritis Activity

Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis


Sponsor

Sherief Abd-Elsalam

Enrollment

75 participants

Start Date

Oct 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Effect of Some Drugs on Rheumatoid Arithritis Activity.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how certain medications affect the activity and severity of rheumatoid arthritis — a long-term autoimmune disease where the body's immune system attacks the lining of the joints, causing pain, stiffness, and swelling that can worsen over time. By tracking how patients respond to different drug combinations, researchers hope to find more effective ways to manage the disease and improve patients' quality of life. The study likely involves measuring disease markers in blood or joint fluid alongside monitoring symptoms. **You may be eligible if...** - You have been diagnosed with rheumatoid arthritis - You are willing to participate in the study and attend follow-up appointments **You may NOT be eligible if...** - You have liver disease (such as cirrhosis or hepatitis) - You have kidney (renal) disease that affects your ability to process medications safely Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRupatadine

Rupatadine 10 mg daily

DRUGMontelukast

Montelukast 10 mg daily


Locations(1)

Sherief Abd-Elsalam

Tanta, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03770923


Related Trials